Ralph is the Founder & CEO of Volpara Health Technologies which develops digital health solutions for personalized, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose. Volpara is an ASX-listed company with a value of over $300 million. Ralph talks about the benefit of being listed and quickly being able to raise follow-on funding.

www.volparasolutions.com